Malattia di De Quervain in fase acuta: studio interventistico randomizzato volto a valutare l’efficacia del trattamento fisioterapico standard (HANDGUIDE), rispetto al trattamento sperimentale dopo esecuzione di terapia infiltrativa ecoguidata

Title

Code

MDQ23

Type

Sperimentale

Start Year

2024

Status

In Corso

Principal Investigator

051-6366368, 051-6366212

federico.pilla@ior.it

Pilla Federico, MD

1st Orthopaedic and Traumatologic Clinic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica I

Director

Faldini Cesare, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. MDQ23

Tuesday 30 January 2024, 16:48

PG0001197_2024_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Malattia di De Quervain in fase acuta: studio interventistico randomizzato volto a valutare l’efficacia del trattamento fisioterapico standard (HANDGUIDE), rispetto al trattamento sperimentale dopo esecuzione di terapia infiltrativa ecoguidata

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in